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Introduction
Alzheimer's disease (AD) histopathology of the cerebral cortex is characterized by an accumulation of amyloid plaques containing the amyloid β-protein (Aβ) and neurofibrillary tangles composed of hyperphosphorylated tau (Mirra et al., 1991) . Yet plaques and tangles are not unique to AD (Terry et al., 1987; 2001) and while the number and distribution of tangles show a moderate correlation with severity of disease (Braak and Braak, 1997; Schonheit et al., 2004) , amyloid burden is a less robust indicator (Dickson, 1997; 2001; Bennett et al., 2006) . Nonetheless, considerable experimental data suggests that Aβ plays an important role in AD pathogenesis (Selkoe, 2001) . For instance, in the brains of humans affected by AD the concentration of aqueous-soluble Aβ predicts the clinical severity of dementia better than either amyloid plaque or neurofibrillary tangle density (Kuo et al., 1996; McLean et al., 1999; Lemere et al., 2002) . Parallel in vitro studies have revealed that soluble oligomeric forms of synthetic Aβ perturb synaptic structure and activity and impair learning and memory whereas Aβ monomer has no adverse effect (Lambert et al., 1998; Hartley et al., 1999; Wang et al., 2002; Klyubin et al., 2004; Wang et al., 2004; Lacor et al., 2007; Puzzo et al., 2008) . Together, these ex vivo and in vitro studies have led to a revision of the amyloid cascade hypothesis; wherein, soluble Aβ oligomers are the primary neurotoxic agents in AD (Klein et al., 2001; Hardy and Selkoe, 2002) . However, the precise identity of these species and their relationship with amyloid plaques still remains unclear (Walsh and Selkoe, 2007) .
Transgenic mouse models over-expressing various forms of human APP develop amyloid pathology, certain synaptic changes, electrophysiological deficits and impairment of learning and memory relevant to AD (Ashe, 2001; Games et al., 2006) . Consequently, such mice have been studied in an effort to identify toxic Aβ assemblies (Westerman et al., 2002; Kawarabayashi et al., 2004; Lesne et al., 2006; Cheng et al., 2007) . The J20 mouse used here expresses APP bearing the Swedish and Indiana mutations, promoting β-secretase cleavage and increasing the Aβ 42 /Aβ 40 ratio, respectively (Mucke et al., 2000) . These mice show an age-dependent deposition of Aβ beginning around ∼ 4-5 months together with various physiological changes that occur both before (Palop et al., 2007) and after the onset of plaque formation (Palop et al., 2003; Moreno et al., 2007) .
Using a sensitive ELISA and a serial extraction procedure to isolate TBS-soluble, triton-soluble and GuHCl-soluble fractions we find that Aβ 1-40 is the predominant Aβ isoform detected in the aqueous extract, whereas Aβ 1-42 is the major species detected in the GuHCl extract. Importantly, detection of aggregated Aβ (i.e. Aβ sedimented by Neurobiology of Disease 36 (2009) 293-302 
